Finally, we generated a xenograft mouse model using primary APL samples transduced with the pMEG-MLL5 or controls to assess the impact of MLL5 on APL cell viability and differentiation in vivo (Fig. 4E). This evidence concerns the gene KMT2E and acute promyelocytic leukemia.